Drugs, biogenic amine targets and the developing brain

Developmental Neuroscience

Volumn 31, Issue 1-2, 2009, Pages 7-22

  Frederick, Aliya L ^a   Stanwood, Gregg D ^b,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Amphetamine; Cocaine; Cognitive development; Developmental neurotoxicity; Dopamine; Norepinephrine; Postnatal development; Prenatal cocaine; Serotonin

Indexed keywords

4 AMINOBUTYRIC ACID; 4,4' ISOPROPYLIDENEDIPHENOL; ACETYLCHOLINE; AMPHETAMINE; BIOGENIC AMINE; COCAINE; DOPAMINE; FLUOXETINE; GLUTAMIC ACID; METHAMPHETAMINE; NORADRENALIN; SEROTONIN; TERBUTALINE;

ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; BEHAVIOR; BRAIN DEVELOPMENT; BRAIN FUNCTION; COGNITION; DEPRESSION; DRUG ABUSE; DRUG DEPENDENCE; HUMAN; NONHUMAN; PARKINSON DISEASE; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

ADULT; AMPHETAMINE-RELATED DISORDERS; ANIMALS; BEHAVIOR; BIOGENIC AMINES; BRAIN; BRAIN CHEMISTRY; CHILD; CHILD DEVELOPMENT; COCAINE-RELATED DISORDERS; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PREGNANCY; PSYCHOTROPIC DRUGS; SUBSTANCE-RELATED DISORDERS; TOXINS, BIOLOGICAL;

EID: 65349094033     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000207490     Document Type: Review

References (255)

1. Abreu-Villaca Y, Seidler FJ, Tate CA, Slotkin TA (2003): Nicotine is a neurotoxin in the adolescent brain: critical periods, patterns of exposure, regional selectivity, and dose thresholds for macromolecular alterations. Brain Res 979: 114-128.
2. Albert PR, Lemonde S (2004): 5-HT1A receptors, gene repression, and depression: guilt by association. Neuroscientist 10: 575-593.
3. Aldridge JE, Meyer A, Seidler FJ, Slotkin TA (2005): Developmental exposure to terbutaline and chlorpyrifos: pharmacotherapy of preterm labor and an environmental neurotoxicant converge on serotonergic systems in neonatal rat brain regions. Toxicol Appl Pharmacol 203: 132-144.
4. Alm H, Kultima K, Scholz B, Nilsson A, Andren PE, Fex-Svenningsen A, Dencker L, Stigson M (2008): Exposure to brominated flame retardant PBDE-99 affects cytoskeletal protein expression in the neonatal mouse cerebral cortex. Neurotoxicology 29: 628-637.
5. Andrade SE, Raebel MA, Brown J, Lane K, Livingston J, Boudreau D, Rolnick SJ, Roblin D, Smith DH, Willy ME, Staffa JA, Platt R (2008): Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 198: 194 e191-e195.
6. Ansorge MS, Zhou M, Lira A, Hen R, Gingrich JA (2004): Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 306: 879-881.
7. Araki KY, Sims JR, Bhide PG (2007): Dopamine receptor mRNA and protein expression in the mouse corpus striatum and cerebral cortex during pre-and postnatal development. Brain Res 1156: 31-45.
8. Arnsten AF, Li BM (2005): Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry 57: 1377-1384.
9. Aschner M, Gannon M (1994): Manganese (Mn) transport across the rat blood-brain barrier: saturable and transferrin-dependent transport mechanisms. Brain Res Bull 33: 345-349.
10. Aschner M, Guilarte TR, Schneider JS, Zheng W (2007): Manganese: recent advances in understanding its transport and neurotoxicity. Toxicol Appl Pharmacol 221: 131-147.
11. Aubert I, Brana C, Pellevoisin C, Giros B, Caille I, Carles D, Vital C, Bloch B (1997): Molecular anatomy of the development of the human substantia nigra. J Comp Neurol 379: 72-87.
12. Bada HS, Das A, Bauer CR, Shankaran S, Lester B, LaGasse L, Hammond J, Wright LL, Higgins R (2007): Impact of prenatal cocaine exposure on child behavior problems through school age. Pediatrics 119:e348-e359.
13. Berkowitz GS, Wetmur JG, Birman-Deych E, Obel J, Lapinski RH, Godbold JH, Holzman IR, Wolff MS (2004): In utero pesticide exposure, maternal paraoxonase activity, and head circumference. Environ Health Perspect 112: 388-391.
14. Biederman J, Faraone SV (2005): Attention-deficit hyperactivity disorder. Lancet 366: 237-248.
15. Blakely RD, De Felice LJ, Hartzell HC (1994): Molecular physiology of norepinephrine and serotonin transporters. J Exp Biol 196: 263-281.
16. Bonnin A, Peng W, Hewlett W, Levitt P (2006): Expression mapping of 5-HT 1 serotonin receptor subtypes during fetal and early postnatal mouse forebrain development. Neuroscience 141: 781-794.
17. Bonnin A, Torii M, Wang L, Rakic P, Levitt P (2007): Serotonin modulates the response of embryonic thalamocortical axons to netrin-1. Nat Neurosci 10: 588-597.
18. Bouchard M, Laforest F, Vandelac L, Bellinger D, Mergler D (2007): Hair manganese and hyperactive behaviors: pilot study of school-age children exposed through tap water. Environ Health Perspect 115: 122-127.
19. Bowen SE, Hannigan JH (2006): Developmental toxicity of prenatal exposure to toluene. AAPS J 8:E419-E424.
20. Broening HW, Morford LL, Inman-Wood SL, Fukumura M, Vorhees CV (2001): 3,4-methylenedioxymethamphetamine (ecstasy)-induced learning and memory impairments depend on the age of exposure during early development. J Neurosci 21: 3228-3235.
21. Brown RM, Crane AM, Goldman PS (1979): Regional distribution of monoamines in the cerebral cortex and subcortical structures of the rhesus monkey: concentrations and in vivo synthesis rates. Brain Res 168: 133-150.
22. Bushnell PJ, Moser VC, MacPhail RC, Oshiro WM, Derr-Yellin EC, Phillips PM, Kodavanti PR (2002): Neurobehavioral assessments of rats perinatally exposed to a commercial mixture of polychlorinated biphenyls. Toxicol Sci 68: 109-120.
23. Caille I, Dumartin B, Le Moine C, Begueret J, Bloch B (1995): Ontogeny of the D 1 dopamine receptor in the rat striatonigral system: an immunohistochemical study. Eur J Neurosci 7: 714-722.
24. Campbell NG, Koprich JB, Kanaan NM, Lipton JW (2006): MDMA administration to pregnant Sprague-Dawley rats results in its passage to the fetal compartment. Neurotoxicol Teratol 28: 459-465.
25. Cappon GD, Pu C, Vorhees CV (2000): Timecourse of methamphetamine-induced neurotoxicity in rat caudate-putamen after single-dose treatment. Brain Res 863: 106-111.
26. Cases O, Vitalis T, Seif I, De Maeyer E, Sotelo C, Gaspar P (1996): Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: role of a serotonin excess during the critical period. Neuron 16: 297-307.
27. Chang L, Alicata D, Ernst T, Volkow N (2007): Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction 102(suppl 1):16-32.
28. Chang L, Smith LM, LoPresti C, Yonekura ML, Kuo J, Walot I, Ernst T (2004): Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure. Psychiatry Res 132: 95-106.
29. Cheslack-Postava K, Fallin MD, Avramopoulos D, Connors SL, Zimmerman AW, Eberhart CG, Newschaffer CJ (2007): Beta2-adrenergic receptor gene variants and risk for autism in the AGRE cohort. Mol Psychiatry 12: 283-291.
30. Cho DH, Lyu HM, Lee HB, Kim PY, Chin K (1991): Behavioral teratogenicity of methamphetamine. J Toxicol Sci 16(suppl 1):37-49.
31. Clark L, Cools R, Robbins TW (2004): The neuropsychology of ventral prefrontal cortex: decision-making and reversal learning. Brain Cogn 55: 41-53.
32. Collette F, Van der Linden M (2002): Brain imaging of the central executive component of working memory. Neurosci Biobehav Rev 26: 105-125.
33. Connors SL, Crowell DE, Eberhart CG, Copeland J, Newschaffer CJ, Spence SJ, Zimmerman AW (2005): Beta2-adrenergic receptor activation and genetic polymorphisms in autism: data from dizygotic twins. J Child Neurol 20: 876-884.
34. Connors SL, Levitt P, Matthews SG, Slotkin TA, Johnston MV, Kinney HC, Johnson WG, Dailey RM, Zimmerman AW (2008): Fetal mechanisms in neurodevelopmental disorders. Pediatr Neurol 38: 163-176.
35. Costa LG, Aschner M, Vitalone A, Syversen T, Soldin OP (2004): Developmental neuropathology of environmental agents. Annu Rev Pharmacol Toxicol 44: 87-110.
36. Cote F, Fligny C, Bayard E, Launay JM, Gershon MD, Mallet J, Vodjdani G (2007): Maternal serotonin is crucial for murine embryonic development. Proc Natl Acad Sci USA 104: 329-334.
37. Crandall JE, Hackett HE, Tobet SA, Kosofsky BE, Bhide PG (2004): Cocaine exposure decreases GABA neuron migration from the ganglionic eminence to the cerebral cortex in embryonic mice. Cereb Cortex 14: 665-675.
38. Crandall JE, McCarthy DM, Araki KY, Sims JR, Ren JQ, Bhide PG (2007): Dopamine receptor activation modulates GABA neuron migration from the basal forebrain to the cerebral cortex. J Neurosci 27: 3813-3822.
39. Crawford CA, Williams MT, Kohutek JL, Choi FY, Yoshida ST, McDougall SA, Vorhees CV (2006): Neonatal 3,4-methylenedioxymethamphetamine (MDMA) exposure alters neuronal protein kinase A activity, serotonin and dopamine content, and [35S]GTPgammaS binding in adult rats. Brain Res 1077: 178-186.
40. Dannlowski U, Ohrmann P, Bauer J, Deckert J, Hohoff C, Kugel H, Arolt V, Heindel W, Kersting A, Baune BT, Suslow T (2008): 5-HTTLPR biases amygdala activity in response to masked facial expressions in major depression. Neuropsychopharmacology 33: 418-424.
41. Degnan KA, Fox NA (2007): Behavioral inhibition and anxiety disorders: multiple levels of a resilience process. Dev Psychopathol 19: 729-746.
42. Dewar KM, Montreuil B, Grondin L, Reader TA (1989): Dopamine D 2 receptors labeled with [3H]raclopride in rat and rabbit brains: equilibrium binding, kinetics, distribution and selectivity. J Pharmacol Exp Ther 250: 696-706.
43. Dewar KM, Reader TA (1989): Distribution of dopamine D 1 and D 2 receptors in rabbit cortical areas, hippocampus, and neostriatum in relation to dopamine contents. Synapse 4: 378-386.
44. Dingemans MM, Ramakers GM, Gardoni F, van Kleef RG, Bergman A, Di Luca M, van den Berg M, Westerink RH, Vijverberg HP (2007): Neonatal exposure to brominated flame retardant BDE-47 reduces long-term potentiation and postsynaptic protein levels in mouse hippocampus. Environ Health Perspect 115: 865-870.
45. Dow-Edwards D, Mayes L, Spear L, Hurd Y (1999): Cocaine and development: clinical, behavioral, and neurobiological perspectives -a symposium report. Neurotoxicol Teratol 21: 481-490.
46. Elliott R (2003): Executive functions and their disorders. Br Med Bull 65: 49-59.
47. Elston GN (2003): Cortex, cognition and the cell: new insights into the pyramidal neuron and prefrontal function. Cereb Cortex 13: 1124-1138.
48. Engel SM, Berkowitz GS, Barr DB, Teitelbaum SL, Siskind J, Meisel SJ, Wetmur JG, Wolff MS (2007): Prenatal organophosphate metabolite and organochlorine levels and performance on the Brazelton Neonatal Behavioral Assessment Scale in a multiethnic pregnancy cohort. Am J Epidemiol 165: 1397-1404.
49. Ericson JE, Crinella FM, Clarke-Stewart KA, Allhusen VD, Chan T, Robertson RT (2007): Prenatal manganese levels linked to childhood behavioral disinhibition. Neurotoxicol Teratol 29: 181-187.
50. Erikson KM, Dorman DC, Fitsanakis V, Lash LH, Aschner M (2006): Alterations of oxidative stress biomarkers due to in utero and neonatal exposures of airborne manganese. Biol Trace Elem Res 111: 199-215.
51. Erikson KM, Thompson K, Aschner J, Aschner M (2007): Manganese neurotoxicity: a focus on the neonate. Pharmacol Ther 113: 369-377.
52. Evans SM, Cone EJ, Henningfield JE (1996): Arterial and venous cocaine plasma concentrations in humans: relationship to route of administration, cardiovascular effects and subjective effects. J Pharmacol Exp Ther 279: 1345-1356.
53. Flores C, Manitt C, Rodaros D, Thompson KM, Rajabi H, Luk KC, Tritsch NX, Sadikot AF, Stewart J, Kennedy TE (2005): Netrin receptor deficient mice exhibit functional reorganization of dopaminergic systems and do not sensitize to amphetamine. Mol Psychiatry 10: 606-612.
54. Forcelli PA, Heinrichs SC (2008): Teratogenic effects of maternal antidepressant exposure on neural substrates of drug-seeking behavior in offspring. Addict Biol 13: 52-62.
55. Francis DD, Caldji C, Champagne F, Plotsky PM, Meaney MJ (1999): The role of corticotropinreleasing factor -norepinephrine systems in mediating the effects of early experience on the development of behavioral and endocrine responses to stress. Biol Psychiatry 46: 1153-1166.
56. Friedman E, Yadin E, Wang HY (1996): Effect of prenatal cocaine on dopamine receptor-G protein coupling in mesocortical regions of the rabbit brain. Neuroscience 70: 739-747.
57. Gabriel M, Taylor C, Burhans L (2003): In utero cocaine, discriminative avoidance learning with low-salient stimuli and learning-related neuronal activity in rabbits ( Oryctolagus cuniculus). Behav Neurosci 117: 912-926.
58. Galineau L, Belzung C, Kodas E, Bodard S, Guilloteau D, Chalon S (2005): Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) exposure induces long-term alterations in the dopaminergic and serotonergic functions in the rat. Brain Res Dev Brain Res 154: 165-176.
59. Garcia SJ, Gellein K, Syversen T, Aschner M (2007): Iron deficient and manganese supplemented diets alter metals and transporters in the developing rat brain. Toxicol Sci 95: 205-214.
60. Gaspar P, Cases O, Maroteaux L (2003): The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci 4: 1002-1012.
61. Gee JR, Moser VC (2008): Acute postnatal exposure to brominated diphenylether 47 delays neuromotor ontogeny and alters motor activity in mice. Neurotoxicol Teratol 30: 79-87.
62. Gingras JL, O'Donnell KJ (1998): State control in the substance-exposed fetus. I. The fetal neurobehavioral profile: an assessment of fetal state, arousal, and regulation competency. Ann NY Acad Sci 846: 262-276.
63. Gingrich JA, Hen R (2001): Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice. Psychopharmacology (Berl) 155: 1-10.
64. Girault JA, Greengard P (2004): The neurobiology of dopamine signaling. Arch Neurol 61: 641-644.
65. Goldman-Rakic PS (1996): The prefrontal landscape: implications of functional architecture for understanding human mentation and the central executive. Philo Trans R Soc Lond B Biol Sci 351: 1445-1453.
66. Goldman-Rakic PS (1998): The cortical dopamine system: role in memory and cognition. Adv Pharmacol 42: 707-711.
67. Goldman-Rakic PS, Lidow MS, Gallager DW (1990): Overlap of dopaminergic, adrenergic, and serotoninergic receptors and complementarity of their subtypes in primate prefrontal cortex. J Neurosci 10: 2125-2138.
68. Gospe SM Jr, Zhou SS (2000): Prenatal exposure to toluene results in abnormal neurogenesis and migration in rat somatosensory cortex. Pediatr Res 47: 362-368.
69. Gressens P, Kosofsky BE, Evrard P (1992): Cocaine-induced disturbances of corticogenesis in the developing murine brain. Neurosci Lett 140: 113-116.
70. Gross C, Zhuang X, Stark K, Ramboz S, Oosting R, Kirby L, Santarelli L, Beck S, Hen R (2002): Serotonin 1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 416: 396-400.
71. Guerriero RM, Rajadhyaksha A, Crozatier C, Giros B, Nosten-Bertrand M, Kosofsky BE (2005): Augmented constitutive CREB expression in the nucleus accumbens and striatum may contribute to the altered behavioral response to cocaine of adult mice exposed to cocaine in utero. Dev Neurosci 27: 235-248.
72. Guilarte TR, McGlothan JL, Degaonkar M, Chen MK, Barker PB, Syversen T, Schneider JS (2006): Evidence for cortical dysfunction and widespread manganese accumulation in the nonhuman primate brain following chronic manganese exposure: a 1 H-MRS and MRI study. Toxicol Sci 94: 351-358.
73. Haber SN, Ryoo H, Cox C, Lu W (1995): Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: comparison with the mRNA for the D 2 receptor, tyrosine hydroxylase and calbindin immunoreactivity. J Comp Neurol 362: 400-410.
74. Harden TK, Wolfe BB, Sporn JR, Perkins JP, Molinoff PB (1977): Ontogeny of beta-adrenergic receptors in rat cerebral cortex. Brain Res 125: 99-108.
75. Hartig PR (1994): Molecular pharmacology of serotonin receptors. EXS 71: 93-102.
76. Harvey JA (2004): Cocaine effects on the developing brain: current status. Neurosci Biobehav Rev 27: 751-764.
77. Hellendall RP, Schambra UB, Liu JP, Lauder JM (1993): Prenatal expression of 5-HT 1C and 5-HT 2 receptors in the rat central nervous system. Exp Neurol 120: 186-201.
78. Herlenius E, Lagercrantz H (2004): Development of neurotransmitter systems during critical periods. Exp Neurol 190(suppl 1):S8-S21.
79. Hirshfeld DR, Rosenbaum JF, Biederman J, Bolduc EA, Faraone SV, Snidman N, Reznick JS, Kagan J (1992): Stable behavioral inhibition and its association with anxiety disorder. J Am Acad Child Adolesc Psychiatry 31: 103-111.
80. Holmes A, le Guisquet AM, Vogel E, Millstein RA, Leman S, Belzung C (2005): Early life genetic, epigenetic and environmental factors shaping emotionality in rodents. Neurosci Biobehav Rev 29: 1335-1346.
81. Hougaard KS, Hass U, Lund SP, Simonsen L (1999): Effects of prenatal exposure to toluene on postnatal development and behavior in rats. Neurotoxicol Teratol 21: 241-250.
82. Hoyer D, Pazos A, Probst A, Palacios JM (1986): Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT 1A recognition sites: apparent absence of 5-HT 1B recognition sites. Brain Res 376: 85-96.
83. Hsieh CT, Liang JS, Peng SS, Lee WT (2007): Seizure associated with total parenteral nutrition-related hypermanganesemia. Pediatr Neurol 36: 181-183.
84. Hyman SE, Malenka RC (2001): Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci 2: 695-703.
85. Jackson MB, Yakel JL (1995): The 5-HT 3 receptor channel. Annu Rev Physiol 57: 447-468.
86. Jayanthi LD, Ramamoorthy S (2005): Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants. AAPS J 7:E728-E738.
87. Jenkins AJ, Keenan RM, Henningfield JE, Cone EJ (2002): Correlation between pharmacological effects and plasma cocaine concentrations after smoked administration. J Anal Toxicol 26: 382-392.
88. Johansson C, Castoldi AF, Onishchenko N, Manzo L, Vahter M, Ceccatelli S (2007): Neurobehavioural and molecular changes induced by methylmercury exposure during development. Neurotox Res 11: 241-260.
89. Jones L, Fischer I, Levitt P (1996): Nonuniform alteration of dendritic development in the cerebral cortex following prenatal cocaine exposure. Cereb Cortex 6: 431-445.
90. Jones LB, Stanwood GD, Reinoso BS, Washington RA, Wang HY, Friedman E, Levitt P (2000): In utero cocaine-induced dysfunction of dopamine D 1 receptor signaling and abnormal differentiation of cerebral cortical neurons. J Neurosci 20: 4606-4614.
91. Jung AB, Bennett JP Jr (1996): Development of striatal dopaminergic function. I. Pre-and postnatal development of mRNAs and binding sites for striatal D 1 (D 1a ) and D 2 (D 2a ) receptors. Brain Res Dev Brain Res 94: 109-120.
92. Kafritsa Y, Fell J, Long S, Bynevelt M, Taylor W, Milla P (1998): Long-term outcome of brain manganese deposition in patients on home parenteral nutrition. Arch Dis Child 79: 263-265.
93. Kagan J, Snidman N (1999): Early childhood predictors of adult anxiety disorders. Biol Psychiatry 46: 1536-1541.
94. Kagan J, Snidman N, Kahn V, Towsley S (2007): The preservation of two infant temperaments into adolescence. Monogr Soc Res Child Dev 72: 1-75, vii, discussion 76-91.
95. Kalivas PW, Volkow ND (2005): The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 162: 1403-1413.
96. Karmel BZ, Gardner JM (1996): Prenatal cocaine exposure effects on arousal-modulated attention during the neonatal period. Dev Psychobiol 29: 463-480.
97. Kasirsky G (1971): Teratogenic effects of methamphetamine in mice and rabbits. J Am Osteopath Assoc 70: 1119-1120.
98. Kebabian JW, Calne DB (1979): Multiple receptors for dopamine. Nature 277: 93-96.
99. Kellendonk C, Simpson EH, Polan HJ, Malleret G, Vronskaya S, Winiger V, Moore H, Kandel ER (2006): Transient and selective overexpression of dopamine D 2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 49: 603-615.
100. Kim H, Lim SW, Kim S, Kim JW, Chang YH, Carroll BJ, Kim DK (2006): Monoamine transporter gene polymorphisms and antidepressant response in Koreans with late-life depression. JAMA 296: 1609-1618.
101. Kiyatkin EA (1995): Functional significance of mesolimbic dopamine. Neurosci Biobehav Rev 19: 573-598.
102. Koprich JB, Chen EY, Kanaan NM, Campbell NG, Kordower JH, Lipton JW (2003): Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) alters exploratory behavior, reduces monoamine metabolism, and increases forebrain tyrosine hydroxylase fiber density of juvenile rats. Neurotoxicol Teratol 25: 509-517.
103. Kuchiiwa S, Cheng SB, Nagatomo I, Akasaki Y, Uchida M, Tominaga M, Hashiguchi W, Kuchiiwa T (2002): In utero and lactational exposure to 2,3,7,8-tetrachlorodibenzo-pdioxin decreases serotonin-immunoreactive neurons in raphe nuclei of male mouse offspring. Neurosci Lett 317: 73-76.
104. Lambe EK, Krimer LS, Goldman-Rakic PS (2000): Differential postnatal development of catecholamine and serotonin inputs to identified neurons in prefrontal cortex of rhesus monkey. J Neurosci 20: 8780-8787.
105. Lauder J, Bloom F (1974a): Ontogeny of monoamine neurons in the locus coeruleus, raphe nuclei, and substantia nigra of the rat. I. Cell differentiation. J Comp Neurol 155: 469-482.
106. Lauder JM, Bloom FE (1974b): Ontogeny of monoamine neurons in the locus coeruleus, raphe nuclei and substantia nigra of the rat. I. Cell differentiation. J Comp Neurol 155: 469-481.
107. Lauder JM, Bloom FE (1975): Ontogeny of monoamine neurons in the locus coeruleus, raphe nuclei and substantia nigra of the rat. II. Synaptogenesis. J Comp Neurol 163: 251-264.
108. Laviola G, Gioiosa L, Adriani W, Palanza P (2005): D -amphetamine-related reinforcing effects are reduced in mice exposed prenatally to estrogenic endocrine disruptors. Brain Res Bull 65: 235-240.
109. Lebrand C, Cases O, Adelbrecht C, Doye A, Alvarez C, El Mestikawy S, Seif I, Gaspar P (1996): Transient uptake and storage of serotonin in developing thalamic neurons. Neuron 17: 823-835.
110. Lee CT, Chen J, Hayashi T, Tsai SY, Sanchez JF, Errico SL, Amable R, Su TP, Lowe RH, Huestis MA, Shen J, Becker KG, Geller HM, Freed WJ (2008): A mechanism for the inhibition of neural progenitor cell proliferation by cocaine. PLoS Med 5:e117.
111. Lee JW (2000): Manganese intoxication. Arch Neurol 57: 597-599.
112. Levin ED, Addy N, Baruah A, Elias A, Christopher NC, Seidler FJ, Slotkin TA (2002): Prenatal chlorpyrifos exposure in rats causes persistent behavioral alterations. Neurotoxicol Teratol 24: 733-741.
113. Levitt P, Moore RY (1978): Noradrenaline neuron innervation of the neocortex in the rat. Brain Res 139: 219-231.
114. Levitt P, Moore RY (1979): Development of the noradrenergic innervation of neocortex. Brain Res 162: 243-259.
115. Levitt P, Rakic P (1982): The time of genesis, embryonic origin and differentiation of the brain stem monoamine neurons in the rhesus monkey. Brain Res 256: 35-57.
116. Levitt P, Rakic P, Goldman-Rakic P (1984): Region-specific distribution of catecholamine afferents in primate cerebral cortex: a fluorescence histochemical analysis. J Comp Neurol 227: 23-36.
117. Lidov HG, Molliver ME (1982): Immunohistochemical study of the development of serotonergic neurons in the rat CNS. Brain Res Bull 9: 559-604.
118. Lidow MS (1995a): D 1 -and D 2 dopaminergic receptors in the developing cerebral cortex of macaque monkey: a film autoradiographic study. Neuroscience 65: 439-452.
119. Lidow MS (1995b): Prenatal cocaine exposure adversely affects development of the primate cerebral cortex. Synapse 21: 332-341.
120. Lidow MS (2003): Consequences of prenatal cocaine exposure in nonhuman primates. Brain Res Dev Brain Res 147: 23-36.
121. Lidow MS, Goldman-Rakic PS, Gallager DW, Rakic P (1991): Distribution of dopaminergic receptors in the primate cerebral cortex: quantitative autoradiographic analysis using [3H]raclopride, [3H]spiperone and [3H]SCH23390. Neuroscience 40: 657-671.
122. Lidow MS, Song ZM (2001): Primates exposed to cocaine in utero display reduced density and number of cerebral cortical neurons. J Comp Neurol 435: 263-275.
123. Lin L, Isacson O (2006): Axonal growth regulation of fetal and embryonic stem cell-derived dopaminergic neurons by Netrin-1 and Slits. Stem Cells 24: 2504-2513.
124. Linares TJ, Singer LT, Kirchner HL, Short EJ, Min MO, Hussey P, Minnes S (2006): Mental health outcomes of cocaine-exposed children at 6 years of age. J Pediatr Psychol 31: 85-97.
125. Lindvall O, Bjorkland A, Divac I (1978): Organization of catecholamine neurons projecting to the frontal cortex of the rat. Brain Res 142: 1-24.
126. Ljung K, Vahter M (2007): Time to re-evaluate the guideline value for manganese in drinking water? Environ Health Perspect 115: 1533-1538.
127. Llansola M, Erceg S, Monfort P, Montoliu C, Felipo V (2007): Prenatal exposure to polybrominated diphenylether 99 enhances the function of the glutamate-nitric oxidecGMP pathway in brain in vivo and in cultured neurons. Eur J Neurosci 25: 373-379.
128. Lu C, Barr DB, Pearson MA, Waller LA (2008): Dietary intake and its contribution to longitudinal organophosphorus pesticide exposure in urban/suburban children. Environ Health Perspect 116: 537-542.
129. Lucki I (1998): The spectrum of behaviors influenced by serotonin. Biol Psychiatry 44: 151-162.
130. Lyles J, Cadet JL (2003): Methylenedioxymethamphetamine (MDMA, ecstasy) neurotoxicity: cellular and molecular mechanisms. Brain Res Brain Res Rev 42: 155-168.
131. Lynd-Balta E, Haber SN (1994a): The organization of midbrain projections to the striatum in the primate: sensorimotor-related striatum versus ventral striatum. Neuroscience 59: 625-640.
132. Lynd-Balta E, Haber SN (1994b): The organization of midbrain projections to the ventral striatum in the primate. Neuroscience 59: 609-623.
133. Malanga CJ, Kosofsky BE (2003): Does drug abuse beget drug abuse? Behavioral analysis of addiction liability in animal models of prenatal drug exposure. Brain Res Dev Brain Res 147: 47-57.
134. Malanga CJ, Riday TT, Carlezon WA Jr, Kosofsky BE (2008): Prenatal exposure to cocaine increases the rewarding potency of cocaine and selective dopaminergic agonists in adult mice. Biol Psychiatry 63: 214-221.
135. Maschi S, Clavenna A, Campi R, Schiavetti B, Bernat M, Bonati M (2008): Neonatal outcome following pregnancy exposure to antidepressants: a prospective controlled cohort study. BJOG 115: 283-289.
136. Mayes L, Snyder PJ, Langlois E, Hunter N (2007): Visuospatial working memory in schoolaged children exposed in utero to cocaine. Child Neuropsychol 13: 205-218.
137. Mayes LC (2002): A behavioral teratogenic model of the impact of prenatal cocaine exposure on arousal regulatory systems. Neurotoxicol Teratol 24: 385-395.
138. Mayes LC, Cicchetti D, Acharyya S, Zhang H (2003): Developmental trajectories of cocaine-and-other-drug-exposed and non-cocaine-exposed children. J Dev Behav Pediatr 24: 323-335.
139. McCann D, Barrett A, Cooper A, Crumpler D, Dalen L, Grimshaw K, Kitchin E, Lok K, Porteous L, Prince E, Sonuga-Barke E, Warner JO, Stevenson J (2007): Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: a randomised, double-blinded, placebo-controlled trial. Lancet 370: 1560-1567.
140. McElhatton PR, Bateman DN, Evans C, Pughe KR, Thomas SH (1999): Congenital anomalies after prenatal ecstasy exposure. Lancet 354: 1441-1442.
141. Melo P, Moreno VZ, Vazquez SP, Pinazo-Duran MD, Tavares MA (2006): Myelination changes in the rat optic nerve after prenatal exposure to methamphetamine. Brain Res 1106: 21-29.
142. Melo P, Pinazo-Duran MD, Salgado-Borges J, Tavares MA (2008): Correlation of axon size and myelin occupancy in rats prenatally exposed to methamphetamine. Brain Res 1222: 61-68.
143. Meyer A, Seidler FJ, Aldridge JE, Slotkin TA (2005): Developmental exposure to terbutaline alters cell signaling in mature rat brain regions and augments the effects of subsequent neonatal exposure to the organophosphorus insecticide chlorpyrifos. Toxicol Appl Pharmacol 203: 154-166.
144. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG (1998): Dopamine receptors: from structure to function. Physiol Rev 78: 189-225.
145. Miyagawa K, Narita M, Narita M, Niikura K, Akama H, Tsurukawa Y, Suzuki T (2007): Changes in central dopaminergic systems with the expression of Shh or GDNF in mice perinatally exposed to bisphenol-A. Nihon Shinkei Seishin Yakurigaku Zasshi 27: 69-75.
146. Moran-Gates T, Gan L, Park YS, Zhang K, Baldessarini RJ, Tarazi FI (2006): Repeated antipsychotic drug exposure in developing rats: dopamine receptor effects. Synapse 59: 92-100.
147. Moreno M, Canadas F, Cardona D, Sunol C, Campa L, Sanchez-Amate MC, Flores P, Sanchez-Santed F (2008): Long-term monoamine changes in the striatum and nucleus accumbens after acute chlorpyrifos exposure. Toxicol Lett 176: 162-167.
148. Morford LL, Inman-Wood SL, Gudelsky GA, Williams MT, Vorhees CV (2002): Impaired spatial and sequential learning in rats treated neonatally with D -fenfluramine. Eur J Neurosci 16: 491-500.
149. Morilak DA, Ciaranello RD (1993): Ontogeny of 5-hydroxytryptamine2 receptor immunoreactivity in the developing rat brain. Neuroscience 55: 869-880.
150. Morris MJ, Dausse JP, Devynck MA, Meyer P (1980): Ontogeny of alpha 1 and alpha 2-adrenoceptors in rat brain. Brain Res 190: 268-271.
151. Morrow BA, Elsworth JD, Roth RH (2002): Prenatal cocaine exposure disrupts non-spatial, short-term memory in adolescent and adult male rats. Behav Brain Res 129: 217-223.
152. Moser VC (2007): Animal models of chronic pesticide neurotoxicity. Hum Exp Toxicol 26: 321-331.
153. Murphy DL, Lesch KP (2008): Targeting the murine serotonin transporter: insights into human neurobiology. Nat Rev Neurosci 9: 85-96.
154. Murphy EH, Fischer I, Friedman E, Grayson D, Jones L, Levitt P, O'Brien-Jenkins A, Wang HY, Wang XH (1997): Cocaine administration in pregnant rabbits alters cortical structure and function in their progeny in the absence of maternal seizures. Exp Brain Res 114: 433-441.
155. Nagatomo S, Umehara F, Hanada K, Nobuhara Y, Takenaga S, Arimura K, Osame M (1999): Manganese intoxication during total parenteral nutrition: report of two cases and review of the literature. J Neurol Sci 162: 102-105.
156. Nasif FJ, Cuadra GR, Ramirez OA (1999): Permanent alteration of central noradrenergic system by prenatally administered amphetamine. Brain Res Dev Brain Res 112: 181-188.
157. Nasuti C, Gabbianelli R, Falcioni ML, Di Stefano A, Sozio P, Cantalamessa F (2007): Dopaminergic system modulation, behavioral changes, and oxidative stress after neonatal administration of pyrethroids. Toxicology 229: 194-205.
158. Nestler EJ (2001): Neurobiology: total recall -the memory of addiction. Science 292: 2266-2267.
159. Nora JJ, Trasler DG, Fraser FC (1965): Malformations in mice induced by dexamphetamine sulphate. Lancet ii:1021-1022.
160. Normandin L, Panisset M, Zayed J (2002): Manganese neurotoxicity: behavioral, pathological, and biochemical effects following various routes of exposure. Rev Environ Health 17: 189-217.
161. Novikova SI, He F, Bai J, Cutrufello NJ, Lidow MS, Undieh AS (2008): Maternal cocaine administration in mice alters DNA methylation and gene expression in hippocampal neurons of neonatal and prepubertal offspring. PLoS ONE 3:e1919.
162. Nowak P, Szczerbak G, Nitka D, Kostrzewa RM, Sitkiewicz T, Brus R (2008): Effect of prenatal lead exposure on nigrostriatal neurotransmission and hydroxyl radical formation in rat neostriatum: Dopaminergic-nitrergic interaction. Toxicology 246: 83-89.
163. Oberlander TF, Bonaguro RJ, Misri S, Papsdorf M, Ross CJ, Simpson EM (2008): Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications. Mol Psychiatry 13: 65-73.
164. Ohtani N, Goto T, Waeber C, Bhide PG (2003): Dopamine modulates cell cycle in the lateral ganglionic eminence. J Neurosci 23: 2840-2850.
165. Olivier B, Mos J, van Oorschot R, Hen R (1995): Serotonin receptors and animal models of aggressive behavior. Pharmacopsychiatry 28(suppl 2):80-90.
166. Olney JW, Wozniak DF, Farber NB, Jevtovic-Todorovic V, Bittigau P, Ikonomidou C (2002): The enigma of fetal alcohol neurotoxicity. Ann Med 34: 109-119.
167. Olson L, Seiger A (1972): Early prenatal ontogeny of central monoamine neurons in the rat: fluorescence histochemical observations. Z Anat Entwicklungsgesch 137: 301-316.
168. Olson L, Seiger A, Fuxe K (1972): Heterogeneity of striatal and limbic dopamine innervation: highly fluorescent islands in developing and adult rats. Brain Res 44: 283-288.
169. Pappas BA, Zhang D, Davidson CM, Crowder T, Park GA, Fortin T (1997): Perinatal manganese exposure: behavioral, neurochemical, and histopathological effects in the rat. Neurotoxicol Teratol 19: 17-25.
170. Parlaman JP, Thompson BL, Levitt P, Stanwood GD (2007): Pharmacokinetic profile of cocaine following intravenous administration in the female rabbit. Eur J Pharmacol 563: 124-129.
171. Pearson KH, Nonacs RM, Viguera AC, Heller VL, Petrillo LF, Brandes M, Hennen J, Cohen LS (2007): Birth outcomes following prenatal exposure to antidepressants. J Clin Psychiatry 68: 1284-1289.
172. Persico AM, Di Pino G, Levitt P (2006): Multiple receptors mediate the trophic effects of serotonin on ventroposterior thalamic neurons in vitro. Brain Res 1095: 17-25.
173. Piper BJ (2007): A developmental comparison of the neurobehavioral effects of ecstasy (MDMA). Neurotoxicol Teratol 29: 288-300.
174. Pittman RN, Minneman KP, Molinoff PB (1980): Ontogeny of beta 1-and beta 2-adrenergic receptors in rat cerebellum and cerebral cortex. Brain Res 188: 357-368.
175. Plessinger MA (1998): Prenatal exposure to amphetamines: risks and adverse outcomes in pregnancy. Obstet Gynecol Clin North Am 25: 119-138.
176. Pranzatelli MR (1993): Regional differences in the ontogeny of 5-hydroxytryptamine-1C binding sites in rat brain and spinal cord. Neurosci Lett 149: 9-11.
177. Rao PA, Molinoff PB, Joyce JN (1991): Ontogeny of dopamine D 1 and D 2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study. Dev Brain Res 60: 161-177.
178. Rauh VA, Garfinkel R, Perera FP, Andrews HF, Hoepner L, Barr DB, Whitehead R, Tang D, Whyatt RW (2006): Impact of prenatal chlorpyrifos exposure on neurodevelopment in the first 3 years of life among inner-city children. Pediatrics 118:e1845-e1859.
179. Reader TA, Dewar KM, Grondin L (1989a): Distribution of monoamines and metabolites in rabbit neostriatum, hippocampus and cortex. Brain Res Bull 23: 237-247.
180. Reader TA, Grondin L, Montreuil B, Dewar KM (1989b): Dopamine D 1 receptors labelled with [3H]SCH23390 in rabbit cerebral cortex and neostriatum: equilibrium binding, kinetics and selectivity. Naunyn Schmiedebergs Arch Pharmacol 340: 617-625.
181. Rebsam A, Seif I, Gaspar P (2002): Refinement of thalamocortical arbors and emergence of barrel domains in the primary somatosensory cortex: a study of normal and monoamine oxidase a knock-out mice. J Neurosci 22: 8541-8552.
182. Reichel CM, Wacan JJ, Farley CM, Stanley BJ, Crawford CA, McDougall SA (2006): Postnatal manganese exposure attenuates cocaine-induced locomotor activity and reduces dopamine transporters in adult male rats. Neurotoxicol Teratol 28: 323-332.
183. Reinoso BS, Undie AS, Levitt P (1996): Dopamine receptors mediate differential morphological effects on cerebral cortical neurons in vitro. J Neurosci Res 43: 439-453.
184. Ren JQ, Malanga CJ, Tabit E, Kosofsky BE (2004): Neuropathological consequences of prenatal cocaine exposure in the mouse. Int J Dev Neurosci 22: 309-320.
185. Rhodes MC, Seidler FJ, Abdel-Rahman A, Tate CA, Nyska A, Rincavage HL, Slotkin TA (2004): Terbutaline is a developmental neurotoxicant: effects on neuroproteins and morphology in cerebellum, hippocampus, and somatosensory cortex. J Pharmacol Exp Ther 308: 529-537.
186. Richardson GA, Conroy ML, Day NL (1996): Prenatal cocaine exposure: effects on the development of school-age children. Neurotoxicol Teratol 18: 627-634.
187. Richardson JR, Caudle WM, Wang M, Dean ED, Pennell KD, Miller GW (2006): Developmental exposure to the pesticide dieldrin alters the dopamine system and increases neurotoxicity in an animal model of Parkinson's disease. FASEB J 20: 1695-1697.
188. Rocha BA, Mead AN, Kosofsky BE (2002): Increased vulnerability to self-administer cocaine in mice prenatally exposed to cocaine. Psychopharmacology (Berl) 163: 221-229.
189. Rodier PM (2004): Environmental causes of central nervous system maldevelopment. Pediatrics 113: 1076-1083.
190. Roegge CS, Timofeeva OA, Seidler FJ, Slotkin TA, Levin ED (2008): Developmental diazinon neurotoxicity in rats: later effects on emotional response. Brain Res Bull 75: 166-172.
191. Romano AG, Harvey JA (1996): Elicitation and modification of the rabbit's nictitating membrane reflex following prenatal exposure to cocaine. Pharmacol Biochem Behav 53: 857-862.
192. Rosenbaum JF, Biederman J, Bolduc-Murphy EA, Faraone SV, Chaloff J, Hirshfeld DR, Kagan J (1993): Behavioral inhibition in childhood: a risk factor for anxiety disorders. Harv Rev Psychiatry 1: 2-16.
193. Rosengarten H, Friedhoff AJ (1979): Enduring changes in dopamine receptor cells of pups from drug administration to pregnant and nursing rats. Science 203: 1133-1135.
194. Rosengarten H, Quartermain D (2002): Effect of prenatal administration of haloperidol, risperidone, quetiapine and olanzapine on spatial learning and retention in adult rats. Pharmacol Biochem Behav 72: 575-579.
195. Sales N, Martres MP, Bouthenet ML, Schwartz JC (1989): Ontogeny of dopaminergic D-2 receptors in the rat nervous system: characterization and detailed autoradiographic mapping with [125I]iodosulpride. Neuroscience 28: 673-700.
196. Scalzo FM, Ali SF, Holson RR, Williams RL (1993): Haloperidol effects on the developing dopamine system: conflicting results and implications for neurobehavioral teratology research. Ann Ist Super Sanita 29: 139-146.
197. Scalzo FM, Spear LP (1985): Chronic haloperidol during development attenuates dopamine autoreceptor function in striatal and mesolimbic brain regions of young and older adult rats. Psychopharmacology (Berl) 85: 271-276.
198. Schaefer TL, Skelton MR, Herring NR, Gudelsky GA, Vorhees CV, Williams MT (2008): Shortand long-term effects of (+)-methamphetamine and (+/-)-3,4-methylenedioxymethamphetamine on monoamine and corticosterone levels in the neonatal rat following multiple days of treatment. J Neurochem 104: 1674-1685.
199. Schambra UB, Duncan GE, Breese GR, Fornaretto MG, Caron MG, Fremeau RT Jr (1994): Ontogeny of D 1A and D 2 dopamine receptor subtypes in rat brain using in situ hybridization and receptor binding. Neuroscience 62: 65-85.
200. Schwartz CE, Snidman N, Kagan J (1999): Adolescent social anxiety as an outcome of inhibited temperament in childhood. J Am Acad Child Adolesc Psychiatry 38: 1008-1015.
201. Segal M, Pickel V, Bloom F (1973): The projections of the nucleus locus coeruleus: an autoradiographic study. Life Sci 13: 817-821.
202. Simansky KJ, Baker G, Kachelries WJ, Hood H, Romano AG, Harvey JA (1998): Prenatal exposure to cocaine reduces dopaminergic D 1 -mediated motor function but spares the enhancement of learning by amphetamine in rabbits. Ann NY Acad Sci 846: 375-378.
203. Simansky KJ, Kachelries WJ (1996): Prenatal exposure to cocaine selectively disrupts motor responding to D -amphetamine in young and mature rabbits. Neuropharmacology 35: 71-78.
204. Singer LT, Minnes S, Short E, Arendt R, Farkas K, Lewis B, Klein N, Russ S, Min MO, Kirchner HL (2004): Cognitive outcomes of preschool children with prenatal cocaine exposure. JAMA 291: 2448-2456.
205. Singer LT, Nelson S, Short E, Min MO, Lewis B, Russ S, Minnes S (2008): Prenatal cocaine exposure: drug and environmental effects at 9 years. J Pediatr 153: 105-111.
206. Singh KP, Singh M (2001): Effect of single prenatal haloperidol exposure on hippocampus and striatum of developing rat brain. Indian J Exp Biol 39: 223-229.
207. Singh KP, Singh M (2002): Effect of prenatal haloperidol exposure on behavioral alterations in rats. Neurotoxicol Teratol 24: 497-502.
208. Skelton MR, Williams MT, Vorhees CV (2008): Developmental effects of 3,4-methylenedioxymethamphetamine: a review. Behav Pharmacol 19: 91-111.
209. Slamberova R, Bernaskova K, Matejovska I, Schutova B (2008): Does prenatal methamphetamine exposure affect seizure susceptibility in adult rats with acute administration of the same drug? Epilepsy Res 78: 33-39.
210. Slotkin TA (1998): Fetal nicotine or cocaine exposure: which one is worse? J Pharmacol Exp Ther 285: 931-945.
211. Slotkin TA (2004): Cholinergic systems in brain development and disruption by neurotoxicants: nicotine, environmental tobacco smoke, organophosphates. Toxicol Appl Pharmacol 198: 132-151.
212. Slotkin TA, Kudlacz EM, Lappi SE, Tayyeb MI, Seidler FJ (1990): Fetal terbutaline exposure causes selective postnatal increases in cerebellar alpha-adrenergic receptor binding. Life Sci 47: 2051-2057.
213. Slotkin TA, Levin ED, Seidler FJ (2006): Comparative developmental neurotoxicity of organophosphate insecticides: effects on brain development are separable from systemic toxicity. Environ Health Perspect 114: 746-751.
214. Slotkin TA, Seidler FJ (2007a): Developmental exposure to terbutaline and chlorpyrifos, separately or sequentially, elicits presynaptic serotonergic hyperactivity in juvenile and adolescent rats. Brain Res Bull 73: 301-309.
215. Slotkin TA, Seidler FJ (2007b): Prenatal chlorpyrifos exposure elicits presynaptic serotonergic and dopaminergic hyperactivity at adolescence: critical periods for regional and sex-selective effects. Reprod Toxicol 23: 421-427.
216. Slotkin TA, Tate CA, Cousins MM, Seidler FJ (2001): Beta-adrenoceptor signaling in the developing brain: sensitization or desensitization in response to terbutaline. Brain Res Dev Brain Res 131: 113-125.
217. Smith L, Yonekura ML, Wallace T, Berman N, Kuo J, Berkowitz C (2003): Effects of prenatal methamphetamine exposure on fetal growth and drug withdrawal symptoms in infants born at term. J Dev Behav Pediatr 24: 17-23.
218. Smith LM, Chang L, Yonekura ML, Grob C, Osborn D, Ernst T (2001): Brain proton magnetic resonance spectroscopy in children exposed to methamphetamine in utero. Neurology 57: 255-260.
219. Smith LM, LaGasse LL, Derauf C, Grant P, Shah R, Arria A, Huestis M, Haning W, Strauss A, Della Grotta S, Liu J, Lester BM (2006): The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics 118: 1149-1156.
220. Smith LM, Lagasse LL, Derauf C, Grant P, Shah R, Arria A, Huestis M, Haning W, Strauss A, Grotta SD, Fallone M, Liu J, Lester BM (2008): Prenatal methamphetamine use and neonatal neurobehavioral outcome. Neurotoxicol Teratol 30: 20-28.
221. Song ZM, Undie AS, Koh PO, Fang YY, Zhang L, Dracheva S, Sealfon SC, Lidow MS (2002): D 1 dopamine receptor regulation of microtubule-associated protein-2 phosphorylation in developing cerebral cortical neurons. J Neurosci 22: 6092-6105.
222. Stanwood GD, Levitt P (2001): The effects of cocaine on the developing nervous system; in Nelson CA, Luciana M (eds): Handbook of Developmental Cognitive Neuroscience. MIT Press, pp 519-536.
223. Stanwood GD, Levitt P (2003): Repeated i.v. cocaine exposure produces long-lasting behavioral sensitization in pregnant adults, but behavioral tolerance in their offspring. Neuroscience 122: 579-583.
224. Stanwood GD, Levitt P (2004): Drug exposure early in life: functional repercussions of changing neuropharmacology during sensitive periods of brain development. Curr Opin Pharmacol 4: 65-71.
225. Stanwood GD, Levitt P (2007): Prenatal exposure to cocaine produces unique developmental and long-term adaptive changes in dopamine D 1 receptor activity and subcellular distribution. J Neurosci 27: 152-157.
226. Stanwood GD, Parlaman JP, Levitt P (2005): Anatomical abnormalities in dopaminoceptive regions of the cerebral cortex of dopamine D(1) receptor mutant mice. J Comp Neurol 487: 270-282.
227. Stanwood GD, Parlaman JP, Levitt P (2006): Genetic or pharmacological inactivation of the dopamine D 1 receptor differentially alters the expression of regulator of G-protein signalling (Rgs) transcripts. Eur J Neurosci 24: 806-818.
228. Stanwood GD, Washington RA, Levitt P (2001a): Identification of a sensitive period of prenatal cocaine exposure that alters the development of the anterior cingulate cortex. Cereb Cortex 11: 430-440.
229. Stanwood GD, Washington RA, Shumsky JS, Levitt P (2001b): Prenatal cocaine exposure produces consistent developmental alterations in dopamine-rich regions of the cerebral cortex. Neuroscience 106: 5-14.
230. Sundstrom E, Kolare S, Souverbie F, Samuelsson EB, Pschera H, Lunell NO, Seiger A (1993): Neurochemical differentiation of human bulbospinal monoaminergic neurons during the first trimester. Brain Res Dev Brain Res 75: 1-12.
231. Suzuki T, Mizuo K, Miyagawa K, Narita M (2005): Exposure to bisphenol-A affects the rewarding system in mice (in Japanese). Nihon Shinkei Seishin Yakurigaku Zasshi 25: 125-128.
232. Suzuki T, Mizuo K, Nakazawa H, Funae Y, Fushiki S, Fukushima S, Shirai T, Narita M (2003): Prenatal and neonatal exposure to bisphenol-A enhances the central dopamine D 1 receptor-mediated action in mice: enhancement of the methamphetamine-induced abuse state. Neuroscience 117: 639-644.
233. Szczerbak G, Nowak P, Kostrzewa RM, Brus R (2007): Maternal lead exposure produces long-term enhancement of dopaminergic reactivity in rat offspring. Neurochem Res 32: 1791-1798.
234. Tavares MA, Silva MC, Silva-Araujo A, Xavier MR, Ali SF (1996): Effects of prenatal exposure to amphetamine in the medial prefrontal cortex of the rat. Int J Dev Neurosci 14: 585-596.
235. Thompson B, Stanwood G, Levitt P (2005a): Double dissociation of the reinforcing properties of cocaine. In: Society For Neuroscience, Washington, DC.
236. Thompson BL, Levitt P, Stanwood GD (2005b): Prenatal cocaine exposure specifically alters spontaneous alternation behavior. Behav Brain Res 164: 107-116.
237. Todd RD (1992): Neural development is regulated by classical neurotransmitters: dopamine D 2 receptor stimulation enhances neurite outgrowth. Biol Psychiatry 31: 794-807.
238. Tran TT, Chowanadisai W, Crinella FM, Chicz-DeMet A, Lonnerdal B (2002): Effect of high dietary manganese intake of neonatal rats on tissue mineral accumulation, striatal dopamine levels, and neurodevelopmental status. Neurotoxicology 23: 635-643.
239. Vorhees CV, Inman-Wood SL, Morford LL, Broening HW, Fukumura M, Moran MS (2000): Adult learning deficits after neonatal exposure to D -methamphetamine: selective effects on spatial navigation and memory. J Neurosci 20: 4732-4739.
240. Vorhees CV, Skelton MR, Williams MT (2007): Age-dependent effects of neonatal methamphetamine exposure on spatial learning. Behav Pharmacol 18: 549-562.
241. Walderhaug E, Magnusson A, Neumeister A, Lappalainen J, Lunde H, Refsum H, Landro NI (2007): Interactive effects of sex and 5-HTTLPR on mood and impulsivity during tryptophan depletion in healthy people. Biol Psychiatry 62: 593-599.
242. Wang HY, Runyan S, Yadin E, Friedman E (1995a): Prenatal exposure to cocaine selectively reduces D 1 dopamine receptor-mediated activation of striatal G s proteins. J Pharmacol Exp Ther 273: 492-498.
243. Wang JH, Yang JZ, Wilson FA, Ma YY (2006): Differently lasting effects of prenatal and postnatal chronic clozapine/haloperidol on activity and memory in mouse offspring. Pharmacol Biochem Behav 84: 468-478.
244. Wang XH, Levitt P, Grayson DR, Murphy EH (1995b): Intrauterine cocaine exposure of rabbits: persistent elevation of GABA-immunoreactive neurons in anterior cingulate cortex but not visual cortex. Brain Res 689: 32-46.
245. Wang XH, Levitt P, O'Brien-Jenkins A, Murphy EH (1996): Normal development of tyrosine hydroxylase and serotonin immunoreactive fibers innervating anterior cingulate cortex and visual cortex in rabbits exposed prenatally to cocaine. Brain Res 715: 221-224.
246. Wasserman GA, Liu X, Parvez F, Ahsan H, Levy D, Factor-Litvak P, Kline J, van Geen A, Slavkovich V, LoIacono NJ, Cheng Z, Zheng Y, Graziano JH (2006): Water manganese exposure and children's intellectual function in Araihazar, Bangladesh. Environ Health Perspect 114: 124-129.
247. Weissman AD, Caldecott-Hazard S (1993): In utero methamphetamine effects. I. Behavior and monoamine uptake sites in adult offspring. Synapse 13: 241-250.
248. Whitaker-Azmitia PM (2001): Serotonin and brain development: role in human developmental diseases. Brain Res Bull 56: 479-485.
249. White KJ, Walline CC, Barker EL (2005): Serotonin transporters: implications for antidepressant drug development. AAPS J 7:E421-E433.
250. Williams MT, Morford LL, Wood SL, Rock SL, McCrea AE, Fukumura M, Wallace TL, Broening HW, Moran MS, Vorhees CV (2003): Developmental 3,4-methylenedioxymethamphetamine (MDMA) impairs sequential and spatial but not cued learning independent of growth, litter effects or injection stress. Brain Res 968: 89-101.
251. Williams MT, Schaefer TL, Ehrman LA, Able JA, Gudelsky GA, Sah R, Vorhees CV (2005): 3,4-Methylenedioxymethamphetamine administration on postnatal day 11 in rats increases pituitary-adrenal output and reduces striatal and hippocampal serotonin without altering SERT activity. Brain Res 1039: 97-107.
252. Won L, Bubula N, Heller A (2002): Fetal exposure to (+/-)- methylenedioxymethamphetamine in utero enhances the development and metabolism of serotonergic neurons in three-dimensional reaggregate tissue culture. Brain Res Dev Brain Res 137: 67-73.
253. Yue Y, Widmer DA, Halladay AK, Cerretti DP, Wagner GC, Dreyer JL, Zhou R (1999): Specification of distinct dopaminergic neural pathways: roles of the Eph family receptor EphB1 and ligand ephrin-B2. J Neurosci 19: 2090-2101.
254. Zerrate MC, Pletnikov M, Connors SL, Vargas DL, Seidler FJ, Zimmerman AW, Slotkin TA, Pardo CA (2007): Neuroinflammation and behavioral abnormalities after neonatal terbutaline treatment in rats: implications for autism. J Pharmacol Exp Ther 322: 16-22.
255. Zhang L, Bai J, Undie AS, Bergson C, Lidow MS (2005): D 1 dopamine receptor regulation of the levels of the cell-cycle-controlling proteins, cyclin D, P27 and Raf-1, in cerebral cortical precursor cells is mediated through cAMP-independent pathways. Cereb Cortex 15: 74-84.